Viridian Therapeutics Stock Forecast - Rate Of Daily Change
| VRDN Stock | USD 21.55 0.32 1.46% |
Viridian Stock Forecast is based on your current time horizon. Although Viridian Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Viridian Therapeutics' systematic risk associated with finding meaningful patterns of Viridian Therapeutics fundamentals over time.
Viridian |
| Previous Rate Of Daily Change | Rate Of Daily Change | Trend |
| 0.99 | 0.99 |
| Check Viridian Therapeutics Volatility | Backtest Viridian Therapeutics | Information Ratio |
Viridian Therapeutics Trading Date Momentum
| On December 01 2024 Viridian Therapeutics was traded for 21.55 at the closing time. The top price for the day was 22.22 and the lowest listed price was 21.26 . There was no trading activity during the period 0.0. Lack of trading volume on December 1, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 1.48% . |
The rate of daily change can indicate whether a given asset was oversold or over brought during a given period.
| Compare Viridian Therapeutics to competition |
Other Forecasting Options for Viridian Therapeutics
For every potential investor in Viridian, whether a beginner or expert, Viridian Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Viridian Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Viridian. Basic forecasting techniques help filter out the noise by identifying Viridian Therapeutics' price trends.Viridian Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Viridian Therapeutics stock to make a market-neutral strategy. Peer analysis of Viridian Therapeutics could also be used in its relative valuation, which is a method of valuing Viridian Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Viridian Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Viridian Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Viridian Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Viridian Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Viridian Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Viridian Therapeutics shares will generate the highest return on investment. By undertsting and applying Viridian Therapeutics stock market strength indicators, traders can identify Viridian Therapeutics entry and exit signals to maximize returns.
Viridian Therapeutics Risk Indicators
The analysis of Viridian Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Viridian Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting viridian stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.2 | |||
| Semi Deviation | 3.45 | |||
| Standard Deviation | 5.36 | |||
| Variance | 28.68 | |||
| Downside Variance | 14.68 | |||
| Semi Variance | 11.88 | |||
| Expected Short fall | (3.75) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Viridian Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Viridian Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Viridian Stock
Moving against Viridian Stock
| 0.59 | INAB | In8bio Inc | PairCorr |
| 0.51 | ELAN | Elanco Animal Health | PairCorr |
| 0.38 | INMB | INmune Bio | PairCorr |
| 0.37 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.33 | TAK | Takeda Pharmaceutical | PairCorr |
The ability to find closely correlated positions to Viridian Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Viridian Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Viridian Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Viridian Therapeutics to buy it.
The correlation of Viridian Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Viridian Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Viridian Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Viridian Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Viridian Therapeutics to cross-verify your projections. To learn how to invest in Viridian Stock, please use our How to Invest in Viridian Therapeutics guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viridian Therapeutics. If investors know Viridian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viridian Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.32) | Revenue Per Share 0.005 | Quarterly Revenue Growth 0.194 | Return On Assets (0.32) | Return On Equity (0.52) |
The market value of Viridian Therapeutics is measured differently than its book value, which is the value of Viridian that is recorded on the company's balance sheet. Investors also form their own opinion of Viridian Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Viridian Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viridian Therapeutics' market value can be influenced by many factors that don't directly affect Viridian Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viridian Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Viridian Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viridian Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.